Cme Group INC Form 4 insider transactions

NASDAQ
Lynne Fitzpatrick, CFO of CME Group, reports the acquisition and disposal of company stock, including shares surrendered for tax obligations.
NASDAQ
Hilda Harris Piell, Sr MD & Chief HR Officer at CME Group Inc., reports the acquisition and disposal of company stock on September 15 and 16, 2024.
NASDAQ
Jonathan L. Marcus, a Senior Managing Director and General Counsel at CME Group Inc., reported the acquisition and disposal of company stock on September 15 and 16, 2024.
NASDAQ
Michael G. Dennis, Global Head of Fixed Income at CME Group, reports the acquisition and disposal of CME Group Class A Common Stock.
NASDAQ
Timothy McCourt, a Senior Managing Director at CME Group, reported the acquisition and disposal of company stock, including shares surrendered for tax obligations and new shares acquired.
NASDAQ
Jack J. Tobin, MD Chief Accounting Officer of CME Group Inc., reports the acquisition and disposal of company stock on September 15 and 16, 2024.
NASDAQ
Julie Winkler, Sr MD Chief Commercial Officer of CME Group Inc., reports the acquisition and disposal of company stock related to tax obligations and stock vesting.
NASDAQ
Derek Sammann, a Senior Managing Director at CME Group, reported the acquisition and disposal of company stock, including shares surrendered for tax obligations and shares acquired.
NASDAQ
Julie Holzrichter, Sr MD Chief Operating Officer of CME Group Inc., reports the acquisition and disposal of company stock.
NASDAQ
Terrence A. Duffy, Chairman and CEO of CME Group, recently acquired 27,456 shares of Class A Common Stock at a price of $218.53 per share.
NASDAQ
Bryan T. Durkin, a director at CME Group Inc., reported selling 7,593 shares of Common Stock Class A at an average price of $214.59 and gifting 465 shares to a charitable organization.
NASDAQ
Director Harold Ford Jr. reports acquiring 748 shares of CME Group Inc. Class A Common Stock at $194.10 per share on June 25, 2024, according to a Form 4 filing.
NASDAQ
Director Patrick Maloney reports acquiring 748 shares of CME Group Inc. Class A common stock at $194.10 per share on June 25, 2024.
NASDAQ
William Shepard, a director at CME Group Inc., reported acquiring shares of Common Stock Class A through a dividend reinvestment plan and the Director Stock Plan.
NASDAQ
Robert J. Tierney Jr., a director at CME Group Inc., acquired 748 shares of Class A Common Stock on June 25, 2024, at a price of $194.1 per share.
NASDAQ
Director Daniel Glickman reports acquiring 748 shares of CME Group Inc. at $194.10 per share on June 25, 2024, and holds 14,756 shares directly and 2,100 indirectly through a trust.
NASDAQ
Director Michael G. Dennis reports acquiring 748 shares of CME Group Inc. Class A common stock at $194.1 per share on June 25, 2024.
NASDAQ
Charles P. Carey, a director at CME Group Inc., reported acquiring 1,237 shares of Common Stock Class A on June 25, 2024, at a price of $194.1 per share.
NASDAQ
Patrick J. Mulchrone, a director at CME Group Inc., reported acquiring 748 shares of Common Stock Class A at a price of $194.1 per share on June 25, 2024.
NASDAQ
Howard J. Siegel, a director at CME Group Inc., reports the acquisition of 1,237 shares of Common Stock Class A at a price of $194.1 per share on June 25, 2024.
NASDAQ
Bryan T. Durkin, a director at CME Group Inc., reported acquiring 748 shares of Class A Common Stock at a price of $194.1 on June 25, 2024, bringing his total holdings to 63,200 shares.
NASDAQ
Timothy S. Bitsberger, a director at CME Group Inc., acquired 748 shares of Class A Common Stock on June 25, 2024, at a price of $194.1 per share.
NASDAQ
Kathryn Benesh, a director at CME Group, acquired 748 shares of Class A Common Stock on June 25, 2024, at a price of $194.1 per share.
NASDAQ
Director Martin J. Gepsman acquired 748 shares of CME Group Inc. at $194.10 per share on June 25, 2024.
NASDAQ
Director Dennis Suskind reports acquiring 748 shares of CME Group Inc. Common Stock Class A at $194.10 per share on June 25, 2024.
NASDAQ
Director Daniel G. Kaye acquired 748 shares of CME Group Inc. common stock under the company's Director Stock Plan.
NASDAQ
Director Larry G. Gerdes of CME Group Inc. reports the acquisition of 1,237 shares of Common Stock Class A at a price of $194.1 per share on June 25, 2024, increasing his total holdings to 40,651.15 shares.
NASDAQ
Phyllis M. Lockett, a director of CME Group Inc., reported acquiring 748 shares of Class A Common Stock on June 25, 2024, at a price of $194.1 per share.
NASDAQ
Director Terry L. Savage reports acquisition of CME Group Inc. shares through a trust.
NASDAQ
Director Rahael Seifu reports acquiring 748 shares of CME Group Inc. Class A common stock at $194.1 per share on June 25, 2024, according to a Form 4 filing.